26
20
Brain Tumor Reports

Volume 12 Supplement 3
March 2012

Home > Publications > Brain Tumor Reports > Volume 12, Year 2012 > Supplement 3, March°


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS





BRAIN TUMORS



Giovagnoli AR.
Investigation of cognitive impairments in people with brain tumors.
J Neurooncol.
2012 Mar 6. doi:10.1007/s11060-012-0815-6 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




González-Vicent M, Molina B, Pérez A, Díaz MA.
Once-daily Intravenous Busulfan for 47 Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Single Center Study.
J Pediatr Hematol Oncol. 2012 Mar 15;.doi: 10.1097/MPH.0b013e3182431e1b [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hélage S, Duyckaerts C, Seilhean D, Hauw JJ, Chiras J.
Association between a Primitive Brain Tumor and Cerebral Aspergillosis.
Case Report Med. 2012;2012:748202. doi: 10.1155/2012/748202 Epub 2012 Feb 20.
Source | Abstract | Full text | Similar articles




Liu S, Zhang C, Shu H, Wion D, Yang H.
Cortical dysplasia: a possible substrate for brain tumors.
Future Oncol. 2012 Mar;8(3):251-8. DOI 10.2217/fon.12.6
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Kalina P.
Pediatric cerebellar hemorrhagic glioblastoma multiforme.
Open Neuroimag J. 2012;6:13-5. Epub 2012 Feb 28.
Source | Abstract | Full text | Similar articles




Karina A, Jonker BP, Morey A, Selinger C, Gupta R, Buckland ME.
Glioblastoma with primitive neuroectodermal tumour-like components.
Pathology. 2012 Apr;44(3):270-3. doi: 10.1097/PAT.0b013e328351bceb
Source | Abstract | Full text | Similar articles




Kim HJ, Kim JH, Chie EK, Park DY, Kim IA, Kim IH.
DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity.
Radiat Oncol. 2012 Mar 20;7(1):39.
DOI: 10.1186/1748-717X-7-39 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kim YS, Kim SH, Cho J, Kim JW, Chang JH, Kim DS, Lee KS, Suh CO.
MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated with Temozolomide-Based Chemoradiotherapy: A Single-Institution Study.
Int J Radiat Oncol Biol Phys. 2012 Mar 11;.http://dx.doi.org/10.1016/j.ijrobp.2011.12.086 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Lehrer S, Green S, Ramanathan L, Rosenzweig K, Labombardi V.
No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and hispanics.
Anticancer Res. 2012 Mar;32(3):1113-5.
Source | Abstract | Full text | Similar articles




McGrane J, Bedford T, Kelly S.
Successful pregnancy and delivery after concomitant temozolomide and radiotherapy treatment of glioblastoma multiforme.
Clin Oncol (R Coll Radiol). 2012 May;24(4):311.http://dx.doi.org/10.1016/j.clon.2012.01.005 Epub 2012 Mar 23.
Source | Abstract | Full text | Similar articles




Munson JM, Fried L, Rowson SA, Bonner MY, Karumbaiah L, Diaz B, Courtneidge SA, Knaus UG, Brat DJ, Arbiser JL, Bellamkonda RV.
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.
Sci Transl Med. 2012 Mar 28;4(127):127ra36. DOI: 10.1126/scitranslmed.3003016
Source | Abstract | Full text | Similar articles




Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Rn PL, Prados M, Goldin J, Wen PY, Cloughesy T.
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.
J Neurooncol. 2012 Mar 18;.doi:10.1007/s11060-012-0847-y
[Epub ahead of print]
Source | Abstract | Full text | Similar articles




Rahbar A, Stragliotto G, Orrego A, Peredo I, Taher C, Willems J, Soderberg-Naucler1 C.
Low levels of Human Cytomegalovirus Infection in Glioblastoma Multiforme associates with patient survival; -a case-control study.
Herpesviridae. 2012 Mar 16;3(1):3. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Reardon DA, Conrad CA, Cloughesy T, Prados MD, Friedman HS, Aldape KD, Mischel P, Xia J, Dilea C, Huang J, Mietlowski W, Dugan M, Chen W, Yung WK.
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients.
Cancer Chemother Pharmacol. 2012 Mar 7;.doi:10.1007/s00280-012-1854-6 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Rodriguez FJ, Orr BA, Ligon KL, Eberhart CG.
Neoplastic cells are a rare component in human glioblastoma microvasculature.
Oncotarget. 2012 Jan;3(1):98-106. doi: 10.18632/oncotarget.427
Source | Abstract | Full text | Similar articles





GLIOMAS



Gozé C, Bezzina C, Gozé E, Rigau V, Maudelonde T, Bauchet L, Duffau H.
1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth.
J Neurooncol. 2012 Mar 6;.
doi:10.1007/s11060-012-0831-6 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ichimura K.
Molecular pathogenesis of IDH mutations in gliomas.
Brain Tumor Pathol. 2012 Mar 8;.doi:10.1007/s10014-012-0090-4 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Juratli TA, Kirsch M, Robel K, Soucek S, Geiger K, von Kummer R, Schackert G, Krex D.
IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas.
J Neurooncol. 2012 Mar 13.
doi:10.1007/s11060-012-0844-1 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Klein M, Duffau H, De Witt Hamer PC.
Cognition and resective surgery for diffuse infiltrative glioma: an overview.
J Neurooncol. 2012 Feb 24;.doi:10.1007/s11060-012-0811-x
[Epub ahead of print]
Source | Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Lombardi G, Zustovich F, Farina P, Polo V, Farina M, Puppa AD, Bertorelle R, Gardiman MP, Berti F, Zagonel V.
Cilengitide in bevacizumab-refractory high-grade glioma: two case reports and critical review of the literature.
Anticancer Drugs. 2012 Feb 29;.DOI: 10.1097/CAD.0b013e3283520e2c [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Reardon DA, Vredenburgh JJ, Desjardins A, Peters KB, Sathornsumetee S, Threatt S, Sampson JH, Herndon JE 2nd, Coan A, McSherry F, Rich JN, McLendon RE, Zhang S, Friedman HS.
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma.
J Neurooncol. 2012 Mar 10;.doi:10.1007/s11060-012-0848-x
[Epub ahead of print]
Source | Abstract | Full text | Similar articles




Strik HM, Marosi C, Kaina B, Neyns B.
Temozolomide Dosing Regimens for Glioma Patients.
Curr Neurol Neurosci Rep. 2012 Mar 22; doi:10.1007/s11910-012-0262-y [Epub ahead of print]
Source | Abstract | Full text | Similar articles




LOW-GRADE GLIOMAS


Gorovets D, Kannan K, Shen R, Kastenhuber E, Islamdoust N, Campos C, Pentsova E, Jhanwar SC, Heguy A, Mellinghoff IK, Chan TA, Huse JT.
IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower-Grade Diffuse Astrocytic Glioma.
Clin Cancer Res. 2012 Mar 13;. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Papagno C, Casarotti A, Comi A, Gallucci M, Riva M, Bello L.
Measuring clinical outcomes in neuro-oncology. A battery to evaluate low-grade gliomas (LGG).
J Neurooncol. 2012 Feb 24.
doi:10.1007/s11060-012-0824-5 [Epub ahead of print]
Source | Abstract | Full text | Similar articles